CLINICAL_TRIALS
trial_result
· 2020-10-08
Clinical Trial Update: Efficacy and Safety Trial of RPC1063 for Moderate to Severe Crohn's Disease [Phase 2]
Summary
Phase 2 trial results for RPC1063 in moderate to severe Crohn's disease have been completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Celgene | Conditions: Crohn's Disease | Phase 2 | Status: COMPLETED | Results posted: 2020-10-08